Search
Please note: using the search filters may not provide accurate search results for records prior to November 2021. When searching for older records, please ensure that you use the include archive checkbox.
Displaying 1 - 7 of 7 items.
COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine): New Formulation/Presentation for Use in Individuals 12 Years of Age and Older
… Last updated 2022-05-09 Summary Product COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine) Issue Health products - New safety …
AlertHealth professional risk communication | 2022-05-09
COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine): New Formulation for Use in Children Aged 5 Years to Less Than 12 Years
… Brand(s) Pfizer-BioNTech COVID-19 Vaccine Last updated 2021-11-19 Summary Product COMIRNATY (COVID-19 Vaccine, mRNA, also referred to as Pfizer-BioNTech COVID-19 Vaccine) Issue Health products - New …
AlertHealth professional risk communication | 2021-11-19
Pfizer-BioNTech COVID-19 Vaccine: Updated Storage and Transportation Conditions
… professionals at the identified Points of Use (POUs). Pfizer is distributing Pfizer-BioNTech COVID-19 Vaccine doses directly to POUs, vaccination …
AlertHealth professional risk communication | 2021-03-08
Authorization of Pfizer-BioNTech COVID-19 Vaccine with English-only Carton and Vial Labels
… professionals at the identified Points of Use (POUs). Pfizer is initially distributing Pfizer-BioNTech COVID-19 Vaccine doses directly to POUs, vaccination …
AlertHealth professional risk communication | 2020-12-12
Pfizer-BioNTech COVID-19 vaccine: Health Canada recommendations for people with serious allergies
… Media enquiries Public enquiries Summary Product: Pfizer-BioNTech COVID-19 vaccine Issue: Two individuals in the U.K. reported severe allergic reactions to Pfizer BioNTech’s COVID-19 vaccine on December 8, 2020. As …
AlertPublic advisory | 2020-12-12
Pfizer-BioNTech COVID-19 Vaccine: Updated Dosage and Administration and Post-Market Adverse Reaction Information
… professionals at the identified Points of Use (POUs). Pfizer is distributing Pfizer-BioNTech COVID-19 Vaccine doses directly to POUs, vaccination …
AlertHealth professional risk communication | 2021-02-09
Health Canada updates Pfizer-BioNTech and Moderna COVID-19 vaccine labels to include information on myocarditis and pericarditis
… number: RA-75959 Last updated: 2021-06-30 Summary Product: Pfizer-BioNTech and Moderna COVID-19 vaccines Issue: Health Canada has updated the product monographs (labels) for the Pfizer-BioNTech and Moderna COVID-19 vaccines to describe …
AlertPublic advisory | 2021-06-30